William Pao Selected Research

William Pao Research Topics

Disease

106	Neoplasms (Cancer) 04/2024 - 07/2003
66	Lung Neoplasms (Lung Cancer) 01/2018 - 09/2004
46	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 02/2004
46	Adenocarcinoma of Lung 10/2016 - 01/2005
9	Disease Progression 01/2018 - 02/2006
9	Adenocarcinoma 11/2013 - 03/2004
7	Melanoma (Melanoma, Malignant) 01/2016 - 01/2012
4	Carcinogenesis 06/2012 - 09/2003
3	Exanthema (Rash) 01/2018 - 04/2011
3	Fatigue 01/2018 - 04/2011
3	Colorectal Neoplasms (Colorectal Cancer) 04/2015 - 09/2003
3	Colonic Neoplasms (Colon Cancer) 07/2012 - 09/2003
3	Sarcoma (Soft Tissue Sarcoma) 01/2012 - 07/2003
3	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 05/2011 - 06/2006
2	Diarrhea 01/2018 - 11/2017
2	Brain Neoplasms (Brain Tumor) 01/2018 - 11/2005
2	Glioblastoma (Glioblastoma Multiforme) 12/2014 - 06/2009
2	Thyroid Neoplasms (Thyroid Cancer) 12/2014 - 11/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2013 - 06/2011
2	Leukemia 01/2012 - 11/2010
2	Neoplasm Metastasis (Metastasis) 12/2011 - 09/2010
2	Breast Neoplasms (Breast Cancer) 11/2011 - 03/2011
2	Glioma (Gliomas) 11/2011 - 11/2005
1	Nausea 01/2018
1	Paronychia 11/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015
1	Ear Neoplasms 05/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Cholangiocarcinoma 12/2014
1	Clinical Deterioration 06/2014
1	Adenosquamous Carcinoma 11/2013

Drug/Important Bio-Agent (IBA)

64	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2004
48	Tyrosine Kinase InhibitorsIBA 01/2018 - 03/2005
45	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 09/2004
40	Gefitinib (Iressa)FDA Link 11/2017 - 02/2004
32	Phosphotransferases (Kinase)IBA 01/2016 - 09/2004
17	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2014 - 02/2004
15	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 08/2005
7	Cetuximab (Erbitux)FDA Link 11/2017 - 10/2009
7	AfatinibIBA 11/2017 - 10/2012
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2015 - 11/2008
7	Proteins (Proteins, Gene)FDA Link 07/2011 - 09/2003
6	Anaplastic Lymphoma KinaseIBA 09/2014 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 11/2011 - 06/2008
5	osimertinibIBA 10/2022 - 09/2014
4	CrizotinibIBA 09/2014 - 12/2011
4	Tyrosine (L-Tyrosine)FDA Link 01/2012 - 12/2007
4	Threonine (L-Threonine)FDA Link 11/2008 - 03/2005
3	Peptides (Polypeptides)IBA 01/2017 - 05/2011
3	NucleotidesIBA 07/2015 - 09/2012
3	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 08/2005
3	Everolimus FDA Link 10/2010 - 08/2007
3	tyrosine receptor (receptor, tyrosine)IBA 10/2009 - 11/2008
3	Methionine (L-Methionine)FDA Link 12/2007 - 03/2005
2	AgarIBA 01/2017 - 01/2014
2	rociletinibIBA 10/2016 - 12/2013
2	Guanine NucleotidesIBA 01/2016 - 07/2014
2	Carrier Proteins (Binding Protein)IBA 01/2016 - 07/2014
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015 - 06/2009
2	Mitogen-Activated Protein KinasesIBA 09/2015 - 11/2008
2	RNA (Ribonucleic Acid)IBA 07/2015 - 12/2013
2	TOR Serine-Threonine KinasesIBA 06/2014 - 10/2010
2	Lapatinib (GW572016)FDA Link 03/2011 - 08/2005
2	CarcinogensIBA 06/2010 - 09/2009
2	Cisplatin (Platino)FDA LinkGeneric 12/2009 - 01/2008
2	Oncogene Proteins (Oncogene Protein)IBA 10/2009 - 09/2003
2	GTP Phosphohydrolases (GTPases)IBA 11/2006 - 01/2005
2	Doxycycline (Periostat)FDA LinkGeneric 06/2006 - 07/2003
1	AntibodiesIBA 04/2024
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2024
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Cancer VaccinesIBA 01/2017
1	HLA-A Antigens (HLA-A)IBA 01/2017
1	CateninsIBA 01/2017
1	CytokinesIBA 03/2016
1	Janus KinasesIBA 03/2016
1	ALW-II-41-27IBA 01/2016
1	GTP-Binding Proteins (G-Protein)IBA 01/2016
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	AmphiregulinIBA 09/2015
1	LigandsIBA 09/2015
1	trametinibIBA 09/2015
1	AZD 6244IBA 06/2015
1	Adenosine Monophosphate (AMP)IBA 12/2014
1	Insulin-Like PeptidesIBA 09/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2014
1	Sirolimus (Rapamycin)FDA Link 06/2014
1	MTOR InhibitorsIBA 06/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2014
1	human PMS2 proteinIBA 01/2014
1	Coal (Coals)IBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 09/2013

Therapy/Procedure

54	Therapeutics 04/2024 - 03/2005
12	Drug Therapy (Chemotherapy) 12/2014 - 01/2005
3	Aftercare (After-Treatment) 10/2016 - 03/2008
2	Radiotherapy 04/2024 - 12/2014
2	Immunotherapy 01/2018 - 01/2017
2	Precision Medicine 01/2018 - 05/2011
2	Adjuvant Chemotherapy 04/2009 - 01/2008
1	Oral Administration 12/2013